GC Therapeutics Secures $75 Million Funding for Revolutionary Stem Cell Technology

GC Therapeutics Funding:
The stem cell startup, spun out of George Church's lab at Harvard Medical School and the Wyss Institute at Harvard University, has raised $75 million in funding.

Technology Focus:
GC Therapeutics is developing a "recipe book" for turning stem cells into nearly any natural human cell type using transcription factor screening technology.

Founding Team:
The startup was co-founded by Parastoo Khoshakhlagh, Alex Ng, and George Church, a renowned figure in the field of genetics and synthetic biology.

Launch and Funding:
The formal launch and funding announcement were made on September 19, 2024, marking a significant milestone for the biotech startup.